Poster

Second-line treatment with modified FOLFIRINOX in patients with pancreatic adenocarcinoma who have failed first-line treatment with gemcitabine and nab-paclitaxel

BackgroundAs new evidence emerges, gemcitabine with nab-paclitaxel is becoming increasingly more popular as first-line chemotherapy for pancreatic cancer due to its efficacy over single a...

06/25/2023

The mechanism of DNA methylation-regulated oncogene SERPINE2 in hepatocellular carcinoma metastasis

BackgroundHepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. Early HCC is mainly resected by surgery, but some patients have recurrence and metastasis with...

06/25/2023

Bidirectional chemotherapy for patients with gastrointestinal peritoneal carcinomatosis

BackgroundPeritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers with highest incidence in gastric and colon cancer. Around 20 % of patients developp i...

A. Hollebecque ;

06/25/2023

Differentiating subcentimeter lung metastases in colorectal cancer patients by radiomics and deep learning approaches: A multicenter study

BackgroundPreoperative evaluation of the indeterminate lung nodules is important for individual treatment of colorectal cancer (CRC). We aim to develop and validate discriminative radiomi...

06/25/2023

Characteristic and clinical outcome of localized gastric cancer; real-world data

BackgroundGastric/gastroesophageal junction (GEJ) cancers have a poor prognosis even when present in earlier stages. Different treatment approaches have been studied to improve its outcom...

A. Aljuhani ;

M. Aseafan ;

A. Sheikh ;

A. Alhanash ;

B. Alshamsan ;

S. Bazarbashi ;

06/25/2023

Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer

BackgroundDespite the use of intensive chemotherapy regimens, most patients with advanced pancreatic cancer rapidly progress after the start of first-line therapy. A lot of them remain in...

06/25/2023

Lenvatinib plus checkpoint inhibitors (ICIs) versus sorafenib plus ICIs as first-line treatment for unresectable hepatocellular carcinoma with Child-Pugh B

BackgroundThe efficacy and safety of tyrosine kinase inhibitors combined with check-point inhibitors (ICIs) in patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh B had n...

06/25/2023

AUM001 potentiates the anti-tumor activity of gemcitabine in an AsPC-1 PDAC model

BackgroundPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with extremely poor survival outcomes and limited therapeutic options. The proliferative and metastatic na...

06/25/2023

Reconsidering the TNM stage in non-metastatic colorectal cancer according to the survival paradox

BackgroundThere was a survival paradox in the AJCC TNM staging manual for colorectal cancer (CRC) - some patients at later stages have a better prognosis than those at earlier stages. We ...

06/25/2023

Noninvasive diagnostic models based on CT scans for differentiating solitary pulmonary metastasis in colorectal cancer patients by artificial intelligence: A multicenter study

BackgroundIndeterminate solitary pulmonary nodules are often encountered on CT scans, and diagnosis of solitary pulmonary metastasis (PM) is important for patients with colorectal cancer ...

06/25/2023